A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected With SARS-CoV-2 in China
Latest Information Update: 06 Feb 2023
At a glance
- Drugs Azvudine (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors Shanghai Henlius Biotech
Most Recent Events
- 16 Jan 2023 New trial record